337 Diagnostic Performance of MRI and CSF Cytology in Detecting Leptomeningeal Metastasis and Recurrence in Medulloblastoma: Implications for Surveillance Strategies

View at publisher Summarise with VIRAT
Authors: Zain Peeran, Poojan D. Shukla, Ryan R.L. Phelps, Harmon Singh Khela, Alexander A. Aabedi, Edward Fisher, Paul McMillan Villalobos, Jennifer Rios, Alyssa Reddy, Cassie Kline, Manish K. Aghi, Nalin Gupta
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

INTRODUCTION: Postoperative surveillance in medulloblastoma is not standardized. Current data support obtaining one CSF sample 14–21 days after surgery and more frequent MRIs during the first year; however, the value of additional CSF cytologies and optimal MRI timing is unclear. Advances in MRI technology also warrant reevaluation of its diagnostic performance relative to CSF for detecting leptomeningeal dissemination (LMD). METHODS: 10,781 MRI and CSF reports from 407 medulloblastoma patients across two institutions were retrospectively reviewed. CSF and MRI reports obtained within 30 days of each other were compared for LMD detection. For sensitivity calculations, the gold standard was LMD or recurrence diagnosed by the oncologist. RESULTS: Mean age was 10.6 [10] years. Most were male (n = 248, 60.9%). Molecular subtypes were: Non-SHH/WNT (n = 160, 39.3%), SHH (n = 78, 19.2%), WNT (n = 39, 9.6%), unknown (n = 130, 31.9%). LMD was diagnosed in 31.4% (n = 128), including 18.7% (n = 76) postoperatively. Recurrence occurred in 29.7% (n = 121). Overall CSF-MRI concordance was 74.0%, highest in WNT (91.1%), vs. SHH (77.7%) and Non-WNT/SHH (70.4%) (p < 0.001). MRI more frequently identified positive or equivocal findings not seen on CSF at 3T (21.1%) vs. 1.5T (16.9%) (p = 0.02). Sensitivities for LMD detection were 85.5% (spine MRI), 49.4% (brain MRI), and 27.1% (CSF). For recurrence detection, sensitivity was 88.2% (spine MRI) and 82.8% (brain MRI). No difference in overall (p = 0.073) or LMD-free survival (p = 0.5) was found between patients with single vs. multiple postoperative CSF cytologies. CONCLUSIONS: Spine MRI is the most sensitive modality for detecting LMD and should be prioritized in surveillance. Multiple CSF cytologies offer limited value, and diagnostic sensitivity varies by subtype and MRI parameters. Current surveillance guidelines are based on limited data; this study provides a robust foundation for data-driven, individualized surveillance in medulloblastoma.

Fields of Study & Subjects

Glioma Diagnosis and Treatment Brain Metastases and Treatment Acute Lymphoblastic Leukemia research

Publication details

Journal / source
Neurosurgery
Volume
72
Issue
Supplement_1
Pages
89–89
Publication date
26 March 2026
Language
EN